Citation Impact
Citing Papers
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
2000 Standout
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
2013
DNA methylation age of human tissues and cell types
2013 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Polycyclic aromatic hydrocarbon‐DNA adducts in liver tissues of hepatocellular carcinoma patients and controls
2002
Primary prevention of hepatocellular carcinoma in developing countries
2000
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
2020
Small-scale soft-bodied robot with multimodal locomotion
2018 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Osteoporosis
2019 Standout
Arsenic-induced oxidative stress and its reversibility
2011
Cancer burden in the year 2000. The global picture
2001 Standout
The toxicology of aflatoxins as a basis for public health decisions
2002
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan
1997
Hepatocellular carcinoma
2016 Standout
An integrated design and fabrication strategy for entirely soft, autonomous robots
2016 StandoutNature
Hepatocellular carcinoma
2018 Standout
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Epidemiological characteristics and risk factors of hepatocellular carcinoma
1997
Global Cancer Statistics, 2002
2005 Standout
Low-level arsenic exposure, AS3MT gene polymorphism and cardiovascular diseases in rural Texas counties
2012
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
2003
Enhanced Duck Hepatitis B Virus Gene Expression Following Aflatoxin B Exposure
1999
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Environmental and chemical carcinogenesis
2004
Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance
2010
Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan
2001
Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy
2015
Hepatitis B virus infection
2009 Standout
Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan
2021
The role of quantitative hepatitis B surface antigen revisited
2016
Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
2015
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Update on Biomarkers of Hepatocellular Carcinoma
2013
Management of Hepatocellular Carcinoma *
2005 Standout
Global cancer statistics
2011 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Non-alcoholic fatty liver disease
2021 Standout
The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight?
1999
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Genome-wide DNA methylation profiles in hepatocellular carcinoma
2012
Printing ferromagnetic domains for untethered fast-transforming soft materials
2018 StandoutNature
The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice
1998
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
DNA damage by mycotoxins
1999
Liver is a Target of Arsenic Carcinogenesis
2008
The control of histone methylation and gene expression by oxidative stress, hypoxia, and metals
2012
Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study
2005
A light-driven artificial flytrap
2017 Standout
Mycotoxins and human disease: a largely ignored global health issue
2009 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Prevalence of hepatic iron overload and association with hepatocellular cancer in end‐stage liver disease: results from the National Hemochromatosis Transplant Registry
2007
Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was Launched
2006
PTEN/MMAC1 mutations in hepatocellular carcinomas
1999
Aflatoxin: A 50-Year Odyssey of Mechanistic and Translational Toxicology
2010
249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma
2005
Environmental factors and risk for hepatocellular carcinoma
2004
Enhancement of finger motion range with compliant anthropomorphic joint design
2016
NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine
2008
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
A model of interaction: Aflatoxins and hepatitis viruses in liver cancer aetiology and prevention
2009
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
2015
A case-control study of risk factors for hepatocellular carcinoma in Henan, China.
1998
Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan
2003
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection
2013
Effects of carcinogen-induced transcription factors on the activation of hepatitis B virus expression in human hepatoblastoma HepG2 cells and its implication on hepatocellular carcinomas
2000
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
2014
Hepatocellular carcinoma
2022 Standout
Population-Attributable Risk of Dietary Aflatoxins and Hepatitis B Virus Infection with Respect to Hepatocellular Carcinoma
2004
Biomedical applications of soft robotics
2018 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Aflatoxin Exposure and Hepatitis C Virus in Advanced Liver Disease in a Hepatitis C Virus–Endemic Area in Taiwan
2007
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem
2013 Standout
Soft robotics: Technologies and systems pushing the boundaries of robot abilities
2016 Standout
Specific mutations of hepatitis B virus in plasma predict liver cancer development
2004
Increased Childhood Liver Cancer Mortality and Arsenic in Drinking Water in Northern Chile
2008
The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea–Conakry, West Africa
2002
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
2016
Perching and takeoff of a robotic insect on overhangs using switchable electrostatic adhesion
2016 Science
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout
Protective Interventions to Prevent Aflatoxin-Induced Carcinogenesis in Developing Countries
2007
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
2003 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study.
2001
Aflatoxin B1 Exposure, Hepatitis B Virus Infection, and Hepatocellular Carcinoma in Taiwan
2009
Predictive Value of BMD for Hip and Other Fractures
2005
Mouse models to study the interaction of risk factors for human liver cancer.
2003
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Soft Robotic Grippers
2018 Standout
Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology
2005 Standout
Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular Carcinoma
2008
Global cancer statistics, 2012
2015 Standout
Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiology
2002
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Works of Liyu Wang being referenced
Prediction of bone fracture by bone mineral density in Taiwanese.
2001
Elevated Aflatoxin Exposure and Increased Risk of Hepatocellular Carcinoma
1996
Prediction Models of Long-Term Cirrhosis and Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: Risk Scores Integrating Host and Virus Profiles
2013
Active Sensing System with In Situ Adjustable Sensor Morphology
2013
Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis
2012
Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan
1996
DOES ARSENIC EXPOSURE INCREASE THE RISK FOR LIVER CANCER?1
2004
Human leukocyte antigen phenotypes and hepatitis C viral load
2004
Large-Payload Climbing in Complex Vertical Environments Using Thermoplastic Adhesive Bonds
2013
Physical Connection and Disconnection Control Based on Hot Melt Adhesives
2012
The Risk Factors for Ultrasound-diagnosed Non-alcoholic Fatty Liver Disease Among Adolescents
2009
Deformation in Soft-Matter Robotics: A Categorization and Quantitative Characterization
2015
Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNA
2007
News from Taiwan
2004